Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Altec Medico IVS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading... Loading... Loading... Loading...

1000.0 Bankruptcy Risk  2015 N/A 2016 N/A 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021e N/A 2022e N/A Bankruptcy risk for industry   2.1% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   0.0% 0.0% 15.9% 13.5% 11.8% 6.2% 16.7% 16.3%   Credit score (0-100)   0 0 14 18 21 38 9 10   Credit rating   N/A N/A BB BB BB BBB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2015 N/A 2016 N/A 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021e N/A 2022e N/A Net sales   0 0 299 474 340 637 637 637   Gross profit   0.0 0.0 182 320 232 212 0.0 0.0   EBITDA   0.0 0.0 182 235 118 147 0.0 0.0   EBIT   0.0 0.0 182 235 107 139 0.0 0.0   Pre-tax profit (PTP)   0.0 0.0 96.0 38.8 107.3 137.1 0.0 0.0   Net earnings   0.0 0.0 0.0 38.8 107.3 119.8 0.0 0.0   Pre-tax profit without non-rec. items   0.0 0.0 96.0 38.8 107 137 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2015 N/A 2016 N/A 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021e N/A 2022e N/A Tangible assets total   0.0 0.0 0.0 0.0 33.7 11.3 0.0 0.0   Shareholders equity total   0.0 0.0 74.0 112 195 315 315 315   Interest-bearing liabilities   0.0 0.0 36.9 33.7 58.6 0.0 0.0 0.0   Balance sheet total (assets)   0.0 0.0 146 170 254 472 315 315   Net Debt   0.0 0.0 -12.3 -96.8 -161 -60.0 -315 -315     See the entire balance sheet 1000.0 Volume  2015 N/A 2016 N/A 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021e N/A 2022e N/A Net sales   0 0 299 474 340 637 637 637   Net sales growth   0.0% 0.0% 0.0% 58.8% -28.4% 87.7% 0.0% 0.0%   Gross profit   0.0 0.0 182 320 232 212 0.0 0.0   Gross profit growth   0.0% 0.0% 0.0% 75.5% -27.4% -8.9% -100.0% 0.0%   Employees   0 0 0 0 0 0 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 -16.0 0.0 0.0 0.0   Balance sheet total (assets)   0 0 146 170 254 472 315 315   Balance sheet change%   0.0% 0.0% 0.0% 16.3% 49.1% 86.1% -33.3% 0.0%   Added value   0.0 0.0 182.2 235.1 123.0 146.7 0.0 0.0   Added value %   0.0% 0.0% 61.0% 49.6% 36.2% 23.0% 0.0% 0.0%   Investments   0 0 0 0 22 -30 -11 0   Net sales trend   0.0 0.0 0.0 1.0 -1.0 1.0 0.0 0.0   EBIT trend   0.0 0.0 1.0 2.0 3.0 4.0 0.0 0.0   1000.0 Profitability  2015 N/A 2016 N/A 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021e N/A 2022e N/A EBITDA %   0.0% 0.0% 61.0% 49.6% 34.8% 23.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 61.0% 49.6% 31.5% 21.8% 0.0% 0.0%   EBIT to gross profit (%)   0.0% 0.0% 100.0% 73.5% 46.0% 65.7% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 8.2% 31.6% 18.8% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 8.2% 34.9% 20.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 32.2% 8.2% 31.6% 21.5% 0.0% 0.0%   ROA %   0.0% 0.0% 124.6% 148.7% 51.4% 38.4% 0.0% 0.0%   ROI %   0.0% 0.0% 164.4% 183.2% 54.5% 43.6% 0.0% 0.0%   ROE %   0.0% 0.0% 0.0% 41.7% 69.9% 47.0% 0.0% 0.0%   1000.0 Solidity  2015 N/A 2016 N/A 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021e N/A 2022e N/A Equity ratio %   0.0% 0.0% 50.6% 66.0% 76.8% 66.7% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 24.2% 12.2% 17.3% 13.7% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 7.7% -15.3% -47.4% 4.3% -49.4% -49.4%   Net int. bear. debt to EBITDA, %   0.0% 0.0% -6.7% -41.2% -136.3% -40.9% 0.0% 0.0%   Gearing %   0.0% 0.0% 49.8% 30.0% 30.1% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% 467.8% 556.9% 3.4% 7.4% 0.0% 0.0%   1000.0 Liquidity  2015 N/A 2016 N/A 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021e N/A 2022e N/A Quick Ratio   0.0 0.0 2.8 2.9 0.0 5.3 0.0 0.0   Current Ratio   0.0 0.0 2.8 2.9 0.0 5.3 0.0 0.0   Cash and cash equivalent   0.0 0.0 49.1 130.5 219.8 60.0 0.0 0.0   1000.0 Capital use efficiency  2015 N/A 2016 N/A 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021e N/A 2022e N/A Trade debtors turnover (days)   0.0 0.0 118.7 18.2 83.6 6.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 49.0% 35.9% 64.7% 72.2% 49.4% 49.4%   Net working capital   0.0 0.0 94.9 112.2 92.1 373.4 0.0 0.0   Net working capital %   0.0% 0.0% 31.8% 23.7% 27.1% 58.6% 0.0% 0.0%   1000.0 Employee efficiency  2015 N/A 2016 N/A 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021e N/A 2022e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 0 0 0 0 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 0 0 0 0 0   EBIT / employee   0 0 0 0 0 0 0 0   Net earnings / employee   0 0 0 0 0 0 0 0